Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler
Abstract. Introduction:. Preliminary clinical studies on medical cannabis (MC) treatment using the Syqe Inhaler showed short-term effectiveness and safety at very low and precise doses of MC. Objectives:. Here, we retrospectively analyzed “real-life” long-term data collected in real time on the pote...
Main Authors: | Joshua Aviram, Daniella Atzmony, Elon Eisenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-06-01
|
Series: | PAIN Reports |
Online Access: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001011 |
Similar Items
-
THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial
by: Joshua Aviram, et al.
Published: (2022-10-01) -
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler
by: Joshua Aviram, et al.
Published: (2023-10-01) -
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
by: Joshua Aviram, et al.
Published: (2020-06-01) -
Effect of inhaled budesonide suspension, administered using a metered dose inhaler, on post-operative sore throat, hoarseness of voice and cough
by: Sunil Rajan, et al.
Published: (2018-01-01) -
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
by: Nicola A. Hanania, et al.
Published: (2020-04-01)